Patents by Inventor Albert B. Seymour

Albert B. Seymour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030054381
    Abstract: This invention provides nucleic acid segments derived from the neurokinin 1 receptor (TACR 1) locus of the human genome, including polymorphic sites. Allele-specific primers and probes hybridizing to these sites and to regions flanking these sites are also provided. This invention further provides methods of analyzing a nucleic acid from an individual or a group of individuals. The nucleic acids, primers, and probes are useful for applications including forensics, paternity testing, medicine, e.g., the correlation of polymorphisms with phenotypic traits, and genetic analysis, e.g., genetic mapping of such phenotypic traits.
    Type: Application
    Filed: May 14, 2002
    Publication date: March 20, 2003
    Applicant: Pfizer Inc.
    Inventors: Jason P. Affourtit, Darcy L. Nelson, Albert B. Seymour, Suzin M. Webb
  • Publication number: 20020155474
    Abstract: The present invention relates to methods for reliably detecting an increased risk of developing an inflammatory disorder in a mammalian patient (e.g., a human being) by detecting at least one copy of an IL-1&bgr; gene haplotype in the patient comprising cytosine nucleotides at positions −31 and +3953. Also provided are kits for performing such methods. In addition, methods for detecting patients who require a higher dosage of an agent that reduces the effect of IL-1&bgr; are also provided.
    Type: Application
    Filed: December 21, 2001
    Publication date: October 24, 2002
    Inventors: Stephanie K. Hall, Patrice M. Milos, Albert B. Seymour